PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs

NCT00385853 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: PTK787/ZK 222584
DRUG: Temozolomide
PROCEDURE: Radiation Therapy

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]